). This plasmid was used as a template for GST-DmHen1ΔC amplification by PCR with DmHen1ΔC-Fw and DmHen1ΔC-Rv. The resulting PCR product contained GST sequence joined to the first 281 aa of DmHen1 followed by the stop codon and XhoI restriction site.
In order to avoid nuclease contamination two-step purification scheme was applied. As a first step affinity chromatography was used as soluble filtered lysate was loaded onto equilibrated 5 ml GSTrap HP column (GE Healthcare; the used Equilibration buffer (pH 7.3) contained 140 mM NaCl, 10 mM Na2HPO4, 2.7 mM KCl, 1.8 mM KH2PO4 and 1 mM EDTA). GST tagged proteins were eluted with 50 mM Tris-HCl (pH 8.0), 10 mM GSH and 1 mM DTT. Then fractions that were enriched in the proteins of interest were further loaded on the 5 ml anion exchange column HiTrap Q HP (GE Healthcare) washed with 50 mM Tris-HCl (pH 8.0). Hen1 proteins were eluted with 1 M NaCl and dialyzed against 25 mM Tris-HCl (pH 8.0), 100 mM NaCl, 1 mM DTT and 0.1% Triton X-100 at first without and later with 50% glycerol, collected and stored at -20°C.
Preparation of templates for in vitro transcription
For in vitro transcription of 43 nt and longer RNA substrates PCR-amplified DNA was used as a template, which itself was amplified from pUC19-T7II-siR43/60 or 80-HDV plasmid with T7II-Fw and HDV-Rv primers.
These plasmids were constructed using pTZ19-siR43/60/80. pTZ19-siR43 was a result of ligation of siR-DNA-43-1/2 with PstI and HindIII (Thermo Scientific) digested vector. pTZ19-siR60 and siR80 was generated after siR-DNA-60-1/2 and siR-DNA-80-1/2, respectively, were ligated with MunI and HindIII (Thermo Scientific) restricted pTZ19-siR43. As initial in vitro transcription experiments resulted in heterogeneous transcripts, T7
class III promoter was changed to class II promoter and HDV ribozyme at the 3' end of each sequence was added. This was done through three steps of PCR amplification: first, sequences of T7 II promoter, respective RNA and 5' of HDV ribozyme were amplified using T7II-Fw and siR-HDV-Rv primers and respective plasmid as a template, second, HDV ribozyme was obtained after PCR from partially complementary HDV-Fw and HDV-Rv primers (1), third, PCR products from first and second steps were mixed and amplified with terminal primers, namely T7II-Fw and HDV-Rv. DNA fragments generated in the last step were ligated with pUC19/SmaI (Thermo Scientific) resulting in pUC19-T7II-siR43/60 or 80-HDV.
All primers used for preparation of longer RNA substrates are listed in Supplementary Table S4 .
RNA modification and analysis on denaturing polyacrylamide gel
RNA modification reactions were performed in 20 µl of reaction volume in the presence of 0.02-0. 
HPLC-MS

Synthesis of Ado-14-Cy3 cofactor
Reaction was monitored performing HPLC/MS experiments, HRMS data were obtained using Agilent 6230
TOF mass spectrometer (ESI). The purification of target cofactor was performed with preparative reversedphase HPLC (column -Agilent Prep-C18, dimensions: 30×150, 10 μm, PN 413910-302). The yield of cofactor was determined according to the data of spectrometer NanoDrop ND-1000 UV/VIS. 
FRET analysis on polyacrylamide gel
For visualization of siR23-Cy3/DNA-2Cy5 FRET pair in PAA gel, siR23 was modified with Cy3 as described above and siR23-CH3 was prepared as a control. Three pairs of RNA/DNA hybrids were annealed: siR23-CH3/DNA, siR23-Cy3/DNA and siR23-Cy3/DNA-2Cy5, mixed with 66.6% glycerol in 7:3 ratio and fractionated on 12% native PAA gel in 0.5 x TB buffer (pH 7.5). The gel was scanned with FLA-5100 Image Reader (Fujifilm) using 532 nm laser for Cy3 detection at 570 nm with LPG filter and for FRET signal registration at 662 nm with LPRF filter. The obtained data were analysed using MultiGauge v.3.0 software (Fujifilm).
SUPPLEMENTARY FIGURES
Supplementary Figure S1 . Chemical structures of AdoMet and its synthetic analogues used in this study.
Supplementary Figure S2 . Characterization of synthetic cofactors (S,R-diastereomers at sulfonium centre) by HPLC and ESI-MS. For Ado-14-Cy3 the absorption at 550 nm, which is indicative of Cy3 fluorophore, was registered. Presented cofactors are characterized by single or double charged molecular ion species in MS spectra: (A) Ado- ) analysis of different terminal nucleosides in the presence of AdoMet 1 or synthetic cofactor analogues. Reactions were performed at 37°C for 0-60 min using 0.2 μM of 32 P-labelled miR173 with different 3' terminal nucleosides, 0.1 mM of AdoMet 1 or its synthetic analogues, 10 mM of Co 2+ and 2 μM of HsHEN1 or DmHen1. Results are mean of two experiments. Calculated kchem values, which were acquired by using first order kinetics and fitting single-exponential equation to experimental data from at least two replicates, are listed in Table 1 . Figure S5 . DmHen1 modifies RNA substrates of different length with identical 3' terminal sequences at similar rate in the presence of AdoMet 1 or its synthetic analogues. Reactions were performed as described in Supplementary Figure S4 with the exception that 0.05 mM of Ado-13-biotin 4 was used instead. Results are mean of two experiments. kchem values are listed in Table 2 . Figure S6 . Scheme of attachment of required fluorophore, Cy5 or Cy5.5, using two-step labelling approach for RNA functionalization. Experimental results are presented in Figure 5B . Figure S7 . One-step labelling of long ssRNAs with bulky side chains of synthetic cofactor analogues -Ado-13-biotin 4 (A) or Ado-14-Cy3 5 (B and C using DmHen1 or DmHen1ΔC, respectively). While the portion of modified 32 P-RNA is seen by the lower mobility of respective bands (A, B and C, left), Cy3 labelling is also detected using 532 nm laser (B and C right). Modification reactions were performed with 1 µM of DmHen1 or DmHen1ΔC, 0.1 µM of 32 P-labeled RNA and 50 µM of Ado-13-biotin 4, 6 µM of Ado-14-Cy3 5 or AdoMet 1 as a control for 30 min at 37°C. Figure S8 . ESI-MS analysis of cytidine alkylated with bulky side chains of synthetic AdoMet analogues. 2 µM of miR173 was modified using 1 µM of DmHen1 in the presence of 100 µM of AdoMet 1 (A), 50 µM of Ado-13-biotin 4 (B) or 6 µM of Ado-14-Cy3 5 (C), digested with P1 nuclease and dephosphorylated to nucleosides. Mass-to-charge ratios of modified 3' terminal cytidine derivatives are indicated in the spectrum and assigned to particular compounds in Supplementary Table S2 . D. Denaturing PAA gel of modified RNA samples analysed by ESI-MS. Figure S9 . FRET-based detection of specific ssRNA labelled with Cy3 using single-step approach. A. let-7a2 and siR23 are efficiently labelled with Cy3. B. Comparison of extracted acceptor fluorescence of DNA-2Cy5 and DNA-5Cy5 by FRET. In the presence of DNA-5Cy5 higher FRET signal is registered, even though 5th position for Cy5 attachment holds no apparent advantage as can be seen from siR23/DNA heteroduplex structure modelled using 3D-Nus Web server (2). Green sphere -2'-O atom of ribose, to which Cy3 moiety is transferred by DmHen1; red spheres -methyl groups of thymine, which are replaced by Cy5 in DNA-2Cy5 and DNA-5Cy5 oligonucleotides at second and at fifth position, respectively. 
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